An ionic liquid-based adjuvant for modulating cellular and humoral immune responses.

Area of Science:

• Vaccinology
• Immunology
• Materials Science

Background:

• Vaccination is crucial for infectious disease prevention globally.
• Adjuvants enhance vaccine-induced immune responses but the range of available materials is limited.
• Expanding adjuvant options is vital for developing vaccines against current and emerging infectious diseases.

Purpose of the Study:

• To introduce and characterize a novel ionic liquid (IL) adjuvant, choline and sorbic acid (ChoSorb).
• To evaluate ChoSorb's ability to generate antigen-specific cellular and humoral immune responses.
• To explore the potential of ILs as a new class of adjuvant materials for vaccine design.

Main Methods:

• Material analysis of the synthesized ionic liquid adjuvant (ChoSorb).
• Assessment of innate immune responses triggered by ChoSorb.
• Evaluation of adaptive immune responses (cellular and humoral) to model and clinical-grade antigens formulated with ChoSorb.

Main Results:

• ChoSorb, an ionic liquid, demonstrated effectiveness as a vaccine adjuvant.
• It successfully induced antigen-specific cellular and humoral immune responses.
• Characterization provided mechanistic insights into ChoSorb's adjuvant activity.

Conclusions:

• Ionic liquids, exemplified by ChoSorb, represent a promising new class of adjuvant materials.
• ChoSorb enhances both cellular and humoral immunity, offering robust protection.
• This finding facilitates future vaccine design and development against diverse infectious agents.